15-Jul-2026
LifeVantage Declares Quarterly Dividend
Globe Newswire (Wed, 6-May 4:06 PM ET)
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
Globe Newswire (Wed, 6-May 4:05 PM ET)
Market Chameleon (Thu, 23-Apr 3:07 AM ET)
LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026
Globe Newswire (Wed, 22-Apr 4:05 PM ET)
LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack
Globe Newswire (Tue, 21-Apr 8:00 AM ET)
LifeVantage Inspires with 'Breakthrough' Announcements at 2026 Momentum Academy in Las Vegas
Globe Newswire (Mon, 20-Apr 8:00 AM ET)
LifeVantage Appointing Terrence Moorehead as Chief Executive Officer
Globe Newswire (Thu, 16-Apr 5:15 PM ET)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Lifevantage trades on the NASDAQ stock market under the symbol LFVN.
As of July 15, 2026, LFVN stock price was flat at $6.20 with 189,617 million shares trading.
LFVN has a beta of 0.79, meaning it tends to be less sensitive to market movements. LFVN has a correlation of 0.02 to the broad based SPY ETF.
LFVN has a market cap of $78.22 million. This is considered a Micro Cap stock.
Last quarter Lifevantage reported $44 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-4 million and missed earnings estimates by -$.05.
In the last 3 years, LFVN traded as high as $27.38 and as low as $3.90.
The top ETF exchange traded funds that LFVN belongs to (by Net Assets): VTI, VXF, AVUV, VTWO, IWC.
LFVN has underperformed the market in the last year with a price return of -48.4% while the SPY ETF gained +22.0%. However, in the short term, LFVN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +51.1% vs +9.0% return in SPY. But in the last 2 weeks, LFVN shares have been beat by the market, returning -0.6% compared to an SPY return of +1.1%.
LFVN support price is $5.85 and resistance is $6.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFVN shares will trade within this expected range on the day.